INSMED Inc·4

Mar 11, 4:12 PM ET

SORIANO JOHN 4

4 · INSMED Inc · Filed Mar 11, 2021

Insider Transaction Report

Form 4
Period: 2021-03-09
SORIANO JOHN
Chief Compliance Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-03-0913,43336,767 total
    Exercise: $30.86Exp: 2028-01-22Common Stock (13,433 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-03-1050036,267 total
    Exercise: $30.86Exp: 2028-01-22Common Stock (500 underlying)
  • Sale

    Common Stock

    2021-03-09$40.38/sh14,130$570,56929,773 total
  • Exercise/Conversion

    Common Stock

    2021-03-10$30.86/sh+500$15,43030,273 total
  • Sale

    Common Stock

    2021-03-10$40.00/sh500$20,00029,773 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-03-0917,34969,395 total
    Exercise: $13.91Exp: 2029-01-03Common Stock (17,349 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-03-0914,13042,390 total
    Exercise: $23.75Exp: 2030-01-03Common Stock (14,130 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-09$30.86/sh+13,433$414,54243,206 total
  • Sale

    Common Stock

    2021-03-09$40.38/sh13,433$542,42529,773 total
  • Sale

    Common Stock

    2021-03-09$40.38/sh17,349$700,55329,773 total
  • Exercise/Conversion

    Common Stock

    2021-03-09$23.75/sh+14,130$335,58843,903 total
  • Exercise/Conversion

    Common Stock

    2021-03-09$13.91/sh+17,349$241,32547,122 total
Footnotes (3)
  • [F1]This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F2]This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F3]The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4